I AM BIO

I AM BIO

By Biotechnology Innovation OrganizationNewsScienceMedicineHealth & FitnessPoliticsLife Sciences
Download on the App Store

I AM BIO episodes

  • Biotech is Climate Tech

    Biotech companies are addressing climate change through innovation—from carbon neutral facilities to agricultural innovations to reduce greenhouse gas emissions. BIO was on the ground at the COP28 UN Climate Change Conference in Dubai to deliver the message that biotech is climate tech.

    Follow us on LinkedIn, X, Facebook and Instagram. 

    Visit us at https://www.bio.org/

    22 min
  • Biotech for our Pets

    More than half of U.S. households include pets, but there has been a lack of medical treatments developed specifically for small animals. Biotech companies are working to change that with new treatment options that both borrow from and, potentially, advance human health discoveries.

    Follow us on LinkedIn, X, Facebook and Instagram. 

    Visit us at https://www.bio.org/

    29 min
  • What We Know About the Microbiome

    The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don’t. Two companies, Bloom Science and Seres Therapeutics, are leveraging the microbiome to develop new therapeutics. The potential of the microbiome is vast, and further research and technological advancements will continue to unlock its benefits.

    Follow us on LinkedIn, X, Facebook and Instagram. 

    Visit us at https://www.bio.org/

    28 min
  • Is CRISPR the New Sickle Cell Savior?

    2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients. 

    Follow us on LinkedIn, X, Facebook and Instagram. 

    Visit us at https://www.bio.org/

    25 min
  • “On My Own”—Desperate to Stop a Resistant Bacterial Infection (REDUX)

    Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to mad scientist, to biotech company founder. In this episode, Bradley takes us through his desperate journey to find a cure. We also talk with the leader of an organization helping to get more antimicrobials to the marketplace.

    Follow us on LinkedIn, X, Facebook and Instagram. 

    Visit us at https://www.bio.org/

    28 min
  • The Synbio Revolution is Here (REDUX)

    Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we’ve entered a synbio revolution, and it holds potential to improve the health of people and our planet. In this episode, we talk with three synbio experts about how this convergence of genetic engineering, computer science and other scientific disciplines is making our world more sustainable. 

    Follow us on LinkedIn, X, Facebook and Instagram. 

    Visit us at https://www.bio.org/

    27 min
  • How Biotechs Survive the Valley of Death (REDUX)

    For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it’s like to struggle and survive in this rough-and-tumble industry.  

    Follow us on LinkedIn, X, Facebook and Instagram. 

    Visit us at https://www.bio.org/

    26 min
  • Biotech Women Striking at the Glass Ceiling (REDUX)

    The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests speak to why women’s leadership matters and the barriers that remain to breaking the glass ceiling. They also tell us about a new networking initiative—the biotech sisterhood—to catalyze women’s success in corporate leadership and mentor the next generation of women executives.  

    Follow us on LinkedIn, X, Facebook and Instagram. 

    Visit us at https://www.bio.org/

    25 min
  • We Need Bees. Bees Need Biotech. (REDUX)

    Bees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That’s why reports of a decline in bee populations and rising threats from pests, viruses and environmental pressures, including climate change, are alarming.

    In this episode we talk with an expert on bees and other pollinators about how bees are doing and why it’s important to save them. We also talk with two biotech leaders whose companies are working to improve bee health through development of innovative treatments for some of the worst threats faced by bees.

    Follow us on LinkedIn, X, Facebook and Instagram. 

    Visit us at https://www.bio.org/

    27 min
  • The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab? (REDUX)

    The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading bacteria, thereby protecting them from the attacking toxins.

    In this episode we talk with three experts about how this animal’s unique blue blood has become essential to modern medicine. We also talk about why horseshoe crab populations are dwindling, and what biotech is doing to address the shortfall.

    Follow us on LinkedIn, X, Facebook and Instagram. 

    Visit us at https://www.bio.org/

    29 min

About I AM BIO

From the publisher's feed

Powerful stories of biotechnology breakthroughs, the people they help, and the global problems they solve.

More shows like I AM BIO

This Week in Virology by Vincent Racaniello

This Week in Virology

2,053 Listeners

Nature Podcast by Springer Nature Limited

Nature Podcast

769 Listeners

TED Talks Science and Medicine by TED

TED Talks Science and Medicine

756 Listeners

Science Talk by Scientific American

Science Talk

600 Listeners

Science Magazine Podcast by Science Magazine

Science Magazine Podcast

817 Listeners

Two Scientists Walk Into a Bar by Genentech

Two Scientists Walk Into a Bar

310 Listeners

The Daily by The New York Times

The Daily

112,266 Listeners

Interchange Recharged by Wood Mackenzie

Interchange Recharged

505 Listeners

FYI - For Your Innovation by ARK Invest

FYI - For Your Innovation

394 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

124 Listeners

The Readout Loud by STAT

The Readout Loud

348 Listeners

The World, the Universe and Us by New Scientist

The World, the Universe and Us

119 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

149 Listeners

Catalyst with Shayle Kann by Latitude Media

Catalyst with Shayle Kann

280 Listeners

What's Your Problem? by iHeartPodcasts and Pushkin Industries

What's Your Problem?

273 Listeners